Pathogenesis of portal hypertension

European Journal of Gastroenterology and Hepatology

Volumn 13, Issue 4, 2001, Pages 309-311

  Lebrec, Didier ^a   Moreau, Richard ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

Cirrhosis; K channels; Keywords; Nitric oxide; Protein kinase C; Systemic circulation

Indexed keywords

VASOCONSTRICTOR AGENT;

ADRENERGIC SYSTEM; HEMODYNAMICS; HUMAN; HYPERKINESIA; HYPERVOLEMIA; PARACRINE SIGNALING; PORTAL HYPERTENSION; PRIORITY JOURNAL; REVIEW; SPLANCHNIC BLOOD FLOW; SYSTEMIC CIRCULATION;

ANIMALS; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION, PORTAL; NITRIC OXIDE; SPLANCHNIC CIRCULATION;

EID: 0035052638     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/00042737-200104000-00002     Document Type: Review

References (23)

1. Lebrec D. Animal models of portal hypertension. In:Portal Hypertension: Clinical and Physiological Aspects. Okuda K, Benhamou JP (editors). Tokyo: Springer-Verlag; 1991. pp. 101 -103.
2. Murray JF, Wawson AM, Sherlock S. Circulatory changes in chronic liver disease. Am J Med 1958; 24: 358 -367.
3. Bayley TJ, Segel N, Bishop JM. The circulatory changes in patients with cirrhosis of the liver at rest and during exercise. Clin Sci 1964; 26: 227 -235.
4. Lebrec D, Bataille C, Bercoff E, Valla D. Hemodynamic changes in patients with portal venous obstruction. Hepatology 1983; 3: 550 -553.
5. Fernandez-Seara J, Prieto J, Quiroga J, Zozaya JM, Cobos MA, Rodriguez-Eire JL. et al. Systemic and regional hemodynamics in patients with liver cirrhosis and ascites with and without functional renal failure. Gastroenterology 1989; 97: 1304 -1312.
6. Braillon A, Calès P, Valla D, Gaudy D, Geoffroy P, Lebrec D. Influence of the degree of liver failure on systemic and splanchic haemodynamics and on response to propranolol in patients with cirrhosis. Gut 1986; 27: 1204 -1209.
7. Henriksen JH, Bendtsen F, Sorensen TIA, Stadeager C, Ring-Larsen H. Reduced central blood volume in cirrhosis. Gastroenterology 1989; 97: 1506 -1513.
8. Moreau R, Lebrec D. Endogenous factors involved in the control of arterial tone in cirrhosis. J Hepatol 1995; 22: 370 -376.
9. Sogni P, Moreau R, Gadano A, Lebrec D. The role of nitric oxide in the hyperdynamic circulatory syndrome associated with portal hypertension. J Hepatol 1995; 23: 218 -224.
10. Pilette C, Kirstetter P, Sogni P, Cailmail S, Moreau R, Lebrec D. The effects of a nitric oxide biosynthesis inhibitor on hyperdynamic circulation in two models of portal hypertensive rats. J Hepatol Gastroenterol 1995; 11: 1 -6.
11. Moncada S, Palmer R, Higgs E. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109 -142.
12. Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: a role for nitric oxide. Lancet 1991; 337: 776 -778.
13. Pateron D, Tazi KA, Sogni P, Heller J, Chagneau C, Poirel O. et al. Role of aortic nitric oxide synthase 3 (eNOS) in the systemic vasodilation of portal hypertension. Gastroenterology 2000; 119: 196 —200.
14. Chagneau C, Tazi KA, Heller J, Sogni P, Poirel O, Moreau R. et al. The role of nitric oxide in the reduction of protein kinase C-induced contractile response in aortae from rats with portal hypertension. J Hepatol 2000; 33: 26 —32.
15. Tazi KA, Moreau R, Heller J, Poirel O, Lebrec D. Changes in protein kinase C isoforms in association with vascular hyporeactivity in cirrhotic rat aortas. Gastroenterology 2000; 119: 201 —210.
16. Oberti F, Sogni P, Cailmail S, Moreau R, Pipy B, Lebrec D. Role of prostacyclin in hemodynamic alterations in conscious rats with extrahepatic or intrahepatic portal hypertension. Hepatology 1993; 18: 621 -627.
17. Cahill PA, Wu YP, Sitzmann JV. Altered adenylyl cyclase activities and G-protein abnormalities in portal hypertensive rabbits. J Clin Invest 1994; 93: 2691 -2700.
18. Gaudin C, Braillon A, Poo JL, Kleber G, Moreau R, Lebrec D. Plasma catecholamines in patients with presinusoidal portal hypertension. Comparison with cirrhotic patients and non portal hypertensive subjects. Hepatology 1991; 13: 913 -916.
19. Lebrec D, Bataille C, Bercoff E, Valla D. Hemodynamic changes in patients with portal vein obstruction. Hepatology 1983; 3: 550 -553.
20. Bihari D, Gimson AES, Lindridge J, Williams R. Lactic acidosis in fulminant hepatic failure. Some aspects of pathogenesis and prognosis. J Hepatol 1985; 1: 405 -416.
21. Braillon A, Calès P, Valla D, Gaudy D, Geoffroy P, Lebrec D. Influence of the degree of liver failure on systemic and splanchnic haemodynamics and on response to propranolol in patients with cirrhosis. Gut 1986; 27: 1204 -1219.
22. Moreau R, Lee SS, Hadengue A, Braillon A, Lebrec D. Hemodynamic effects of a clonidine-induced decrease in sympathetic tone in patients with cirrhosis. Hepatology 1987; 7: 149 -154.
23. Cereda JM, Roulot D, Braillon A, Moreau R, Koshy A, Lebrec D. Reduction of portal pressure by acute administration of furosemide in patients with alcoholic cirrhosis. J Hepatol 1989; 9: 246 -251.